• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢癌中组织蛋白酶D免疫反应性:与预后因素的相关性

Cathepsin D immunoreactivity in ovarian cancer: correlation with prognostic factors.

作者信息

Athanassiadou P, Sakellariou V, Petrakakou E, Athanassiades P, Zerva C, Liossi A, Michalas S

机构信息

Athens University, Pathology Laboratory, Department of Cytology, Athen, Greece.

出版信息

Pathol Oncol Res. 1998;4(2):103-7. doi: 10.1007/BF02904702.

DOI:10.1007/BF02904702
PMID:9654594
Abstract

In view of the somewhat inconclusive nature of the reports of the role of Cathepsin D (Cath D) in ovarian carcinoma and its relationship with various other parameters of malignancy the present study was performed to aid in the further clarification of this role. One hundred freshly resected primary ovarian carcinomas of various histological types were studied for ER, PR and Cath D status and the results examined with respect to menopausal status, histology, size and lymph node invasion. In our series Cath D positivity was more frequent in serous than in other types of ovarian cancer but this Cath D positivity was not related to the frequency of lymph node invasion regardless of the size of the tumor. Nor was any association observed between Cath D positivity and ER or PR status of the tumors or the menopausal state of the patients. The reported prognostic value of Cath D, ER and PR is discussed as well as the distinction between tumor invasion by lymphatic channels and direct interstitial infiltration. It was concluded that Cath D may not play a role in the former mode but, as might be expected from its proteolytic properties, in local spread by means of tissue destruction.

摘要

鉴于组织蛋白酶D(Cath D)在卵巢癌中的作用及其与其他各种恶性参数的关系的报道有些不确定,进行了本研究以帮助进一步阐明这一作用。对100例新鲜切除的各种组织学类型的原发性卵巢癌进行了雌激素受体(ER)、孕激素受体(PR)和Cath D状态的研究,并根据绝经状态、组织学、大小和淋巴结浸润情况对结果进行了检查。在我们的系列研究中,浆液性卵巢癌中Cath D阳性比其他类型的卵巢癌更常见,但这种Cath D阳性与淋巴结浸润频率无关,无论肿瘤大小如何。在肿瘤的Cath D阳性与ER或PR状态或患者的绝经状态之间也未观察到任何关联。讨论了所报道的Cath D、ER和PR的预后价值以及淋巴管侵袭与直接间质浸润之间的区别。得出的结论是,Cath D可能在前一种模式中不起作用,但正如从其蛋白水解特性所预期的那样,在通过组织破坏进行的局部扩散中起作用。

相似文献

1
Cathepsin D immunoreactivity in ovarian cancer: correlation with prognostic factors.卵巢癌中组织蛋白酶D免疫反应性:与预后因素的相关性
Pathol Oncol Res. 1998;4(2):103-7. doi: 10.1007/BF02904702.
2
Immunocytochemical localization of Cathepsin D and CA 125 in ovarian cancer.
Int J Gynaecol Obstet. 1997 Jan;56(1):31-7. doi: 10.1016/s0020-7292(96)02792-0.
3
Cathepsin-D in human breast cancer: correlation with vascular invasion and other clinical and histopathological characteristics.组织蛋白酶-D与人乳腺癌:与血管侵犯及其他临床和组织病理学特征的相关性
Anticancer Res. 1993 Nov-Dec;13(6A):2131-5.
4
Expression of cathepsin-D, CA125 and epidermal growth factor receptor in imprint smears of ovarian carcinoma.
Gynecol Obstet Invest. 1997;43(2):125-30. doi: 10.1159/000291837.
5
Cathepsin D assay in ovarian cancer: correlation with pathological features and receptors for oestrogen, progesterone and epidermal growth factor.卵巢癌中组织蛋白酶D检测:与病理特征及雌激素、孕激素和表皮生长因子受体的相关性
Br J Cancer. 1991 Jul;64(1):182-4. doi: 10.1038/bjc.1991.266.
6
Cathepsin D assay in primary breast cancer and lymph nodes: relationship with c-myc, c-erb-B-2 and int-2 oncogene amplification and node invasiveness.原发性乳腺癌及淋巴结中的组织蛋白酶D检测:与c-myc、c-erb-B-2及int-2癌基因扩增和淋巴结浸润的关系
Eur J Cancer. 1990 Apr;26(4):437-41. doi: 10.1016/0277-5379(90)90012-i.
7
[Estrogens, cathepsin D and metastasis in cancers of the breast and ovary: invasion or proliferation?].[雌激素、组织蛋白酶D与乳腺癌和卵巢癌转移:侵袭还是增殖?]
C R Seances Soc Biol Fil. 1998;192(2):241-51.
8
The potential prognostic value of cathepsin D protein in serous ovarian cancer.组织蛋白酶 D 蛋白在浆液性卵巢癌中的潜在预后价值。
Arch Gynecol Obstet. 2012 Aug;286(2):465-71. doi: 10.1007/s00404-012-2318-2. Epub 2012 Apr 3.
9
Immunoenzymatic assay of Mr 52,000 cathepsin D in 182 breast cancer cytosols: low correlation with other prognostic parameters.182例乳腺癌细胞溶质中52,000道尔顿组织蛋白酶D的免疫酶测定:与其他预后参数的低相关性
Cancer Res. 1988 Jan 15;48(2):462-6.
10
Immunohistochemical and immunoradiometric evaluations of total cathepsin D in human larynx.
Eur J Cancer B Oral Oncol. 1994 Jan;30B(1):51-5. doi: 10.1016/0964-1955(94)90051-5.

引用本文的文献

1
Effect of Productive Human Papillomavirus 16 Infection on Global Gene Expression in Cervical Epithelium.人乳头瘤病毒 16 型感染对宫颈上皮全局基因表达的影响。
J Virol. 2018 Sep 26;92(20). doi: 10.1128/JVI.01261-18. Print 2018 Oct 15.
2
Correlation between estrogen receptor expression and prognosis in epithelial ovarian cancer: a meta-analysis.上皮性卵巢癌中雌激素受体表达与预后的相关性:一项荟萃分析。
Oncotarget. 2017 May 29;8(37):62400-62413. doi: 10.18632/oncotarget.18253. eCollection 2017 Sep 22.
3
Prognostic value of progesterone receptor expression in ovarian cancer: a meta-analysis.

本文引用的文献

1
Prognostic indicators for early-stage breast-carcinoma .2. Value of cathepsin-d expression, detected by immunocytochemistry - a multiparametric study.早期乳腺癌的预后指标.2. 免疫细胞化学检测组织蛋白酶 D 表达的价值 - 一项多参数研究。
Int J Oncol. 1994 Sep;5(3):559-64. doi: 10.3892/ijo.5.3.559.
2
Effect of tumor size on the association between ps2 and cathepsin-d in primary breast-cancer.肿瘤大小对原发性乳腺癌中ps2与组织蛋白酶d之间关联的影响。
Int J Oncol. 1995 Jan;6(1):69-73. doi: 10.3892/ijo.6.1.69.
3
Prognostic significance of cathepsin-D in patients with breast cancer.
孕激素受体表达在卵巢癌中的预后价值:一项荟萃分析。
Oncotarget. 2017 May 30;8(22):36845-36856. doi: 10.18632/oncotarget.15982.
4
Combined in vivo molecular and anatomic imaging for detection of ovarian carcinoma-associated protease activity and integrin expression in mice.在体分子与解剖成像联合检测小鼠卵巢癌相关蛋白酶活性及整合素表达。
Neoplasia. 2012 Jun;14(6):451-62. doi: 10.1596/neo.12480.
5
Cathepsin D expression levels in nongynecological solid tumors: clinical and therapeutic implications.组织蛋白酶D在非妇科实体瘤中的表达水平:临床及治疗意义
Clin Exp Metastasis. 2004;21(2):91-106. doi: 10.1023/b:clin.0000024740.44602.b7.
组织蛋白酶-D在乳腺癌患者中的预后意义。
Br J Cancer. 1993 Apr;67(4):767-72. doi: 10.1038/bjc.1993.139.
4
Evaluation of cathepsin D as a prognostic factor in breast cancer.组织蛋白酶D作为乳腺癌预后因素的评估
Breast Cancer Res Treat. 1993;24(3):219-26. doi: 10.1007/BF01833262.
5
The role of cathepsin D in the invasiveness of human breast cancer cells.组织蛋白酶D在人乳腺癌细胞侵袭中的作用。
Cancer Res. 1993 Feb 15;53(4):873-7.
6
Immunoradiometric detection of pS2 and total cathepsin D in primary breast cancer biopsies: their correlation with steroid receptors.原发性乳腺癌活检中pS2和总组织蛋白酶D的免疫放射分析检测:它们与类固醇受体的相关性
Br J Cancer. 1994 Mar;69(3):550-4. doi: 10.1038/bjc.1994.100.
7
Proliferation of renal cell carcinoma assessed by fixation-resistant polyclonal Ki-67 antibody labeling. Correlation with clinical outcome.通过抗固定多克隆Ki-67抗体标记评估肾细胞癌的增殖。与临床结果的相关性。
Cancer. 1995 Jun 1;75(11):2714-9. doi: 10.1002/1097-0142(19950601)75:11<2714::aid-cncr2820751113>3.0.co;2-x.
8
Analysis of the epitopes of proliferating cell nuclear antigen recognized by monoclonal antibodies.单克隆抗体识别的增殖细胞核抗原表位分析
Lab Invest. 1993 Feb;68(2):204-10.
9
Estrogen - and gestagen - receptors in ovarian carcinoma.
Gynecol Obstet Invest. 1983;16(4):189-98. doi: 10.1159/000299256.
10
Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.抗生物素蛋白-生物素-过氧化物酶复合物(ABC)在免疫过氧化物酶技术中的应用:ABC法与未标记抗体(PAP)法的比较。
J Histochem Cytochem. 1981 Apr;29(4):577-80. doi: 10.1177/29.4.6166661.